Carmen Martín-Gómez

Carmen Martín-Gómez

Auto-generated profile, based on publicly available information

Carmen Martín-Gómez

Andalusian Health Technology Assessment Area (AETSA), Andalusian Public Foundation Progress and Health, Junta de Andalucia, Seville, Spain; Research Group HUM604: Lifestyle Development in the Life Cycle and Health Promotion, University of Huelva, Huelva, Spain

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2022 in Psychological Medicine
Verified
Journal Article
Closed access
PDF file
CMCarmen Martín-Gómez
Carmen Martín-Gómez
PMPatricia Moreno-Peral
Patricia Moreno-Peral
JBJuan A. Bellón
Juan A. Bellón
SCSonia Conejo-Cerón
Sonia Conejo-Cerón
HCHenar Campos-Paino
Henar Campos-Paino
Emma MotricoEmma Motrico
Emma Motrico
Postpartum depression (PPD) is one of the most common disorders following childbirth. This systematic review and meta-analysis (SR/MA) aimed to assess the effectiveness of psychological interventions in preventing PPD in non-depressed women. PRISMA guidelines were followed. MEDLINE (Ovid and PubMed), PsycINFO, Web of Science, Scopus, CINAHL, CENTRAL, OpenGrey, Australian New Zealand Clinical Trial Registry and clinicaltrial.gov were searched. Randomized controlled trials (RCTs) conducted with pregnant or postpartum (up to 12 months) women who were non-depressed at baseline were selected. The outcomes were the incidence of PPD and/or the reduction of postpartum depressive symptoms. The standardized mean difference (SMD) using random-effect models was calculated. Sensitivity, sub-group and meta-regression analyses were performed. 17 RCTs were included in the SR and 15 in the MA, representing 4958 participants from four continents. The pooled SMD was −0.175 [95% confidence interval (CI) −0.266 to −0.083;p< 0.001] and sensitivity analyses confirmed the robustness of this result. Heterogeneity was low (I2 = 21.20%) and was fully explained by a meta-regression model including one variable (previous deliveries). The meta-regression model and MA stratified by previous deliveries indicated that interventions focused on primiparous women are more effective. There was no evidence of publication bias. Few RCTs had an overall low risk of bias. According to GRADE, the quality of evidence was moderate. Psychological interventions have very little effectiveness in preventing PPD in non-depressed women, although this effectiveness is greater in interventions focused on primiparous women. Further RCTs with a low risk of bias and more effective interventions are needed.

1 July 2020 in Clinical Psychology Review
Verified
Journal Article
Closed access
SCSonia Conejo-Cerón
Sonia Conejo-Cerón
JBJuan Ángel Bellón
Juan Ángel Bellón
Emma MotricoEmma Motrico
Emma Motrico
HCHenar Campos-Paíno
Henar Campos-Paíno
CMCarmen Martín-Gómez
Carmen Martín-Gómez
PMPatricia Moreno-Peral
Patricia Moreno-Peral

17 May 2020 in BMJ Open
Verified
Journal Article
Open access
CMCarmen Martín-Gómez
Carmen Martín-Gómez
PMPatricia Moreno-Peral
Patricia Moreno-Peral
JBJuan A. Bellón
Juan A. Bellón
SCSonia Conejo-Cerón
Sonia Conejo-Cerón
HCHenar Campos-Paino
Henar Campos-Paino
Emma MotricoEmma Motrico
Emma Motrico
Introduction: The prevalence of postpartum depression (PPD) is 17%, and the incidence is 12% worldwide. Adverse consequences for mothers and babies have been associated with this disease. To assess the effectiveness of psychological, psychoeducational and psychosocial interventions in preventing PPD, a systematic review and meta-analysis (SR/MA) will be conducted. Methods and analysis: A SR/MA will be performed following the indications of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies will be identified through MEDLINE (Ovid and PubMed), PsycINFO, Web of Science, Scopus, CINAHL, Cochrane Central Register of Controlled Trials, OpenGrey, Australian New Zealand Clinical Trial Registry, ClinicalTrials.gov and evidencebasedtherapy.org from inception until 31 January 2020. Bridging searches will be also conducted until the review is completed. The selection criteria will be as follows: (1) subjects will be pregnant females or females who have given birth in the last 12 months and who were non-depressive at baseline; (2) psychological, psychoeducational and psychosocial interventions; (3) comparator will be usual care, attention control, waiting list or no intervention; (4) outcomes will be specific results on PPD; and (5) the design of the studies will be randomised controlled trials. No restrictions regarding the year of publication, the setting of the intervention or the language of publication will be considered. Pooled standardised mean differences and 95% CIs will be calculated. The risk of bias of the studies will be assessed through the Cochrane Collaboration risk of bias tool. Heterogeneity between the studies will be determined by the I 2 and Cochran’s Q statistics. Sensitivity and subgroup analyses will also be performed. Publication bias will be checked with funnel plots and Egger’s test. Heterogeneity will be explored by random-effects meta-regression analysis. Ethics and dissemination: The ethical assessment was not required. The results will be presented at conferences and disseminated through publications. PROSPERO registration number: CRD42018109981.

13 January 2025 in New Directions for Child and Adolescent Development
Verified
Journal Article
Open access
Diego Gomez-BayaDiego Gomez-Baya
Diego Gomez-Baya
Antonio David Martin-BarradoAntonio David Martin-Barrado
Antonio David Martin-Barrado
AGAnna-Jean Grasmeijer
Anna-Jean Grasmeijer
CMCarmen Martin-Gomez
Carmen Martin-Gomez
MPM. Soledad Palacios-Galvez
M. Soledad Palacios-Galvez
EMElena Morales-Marente
Elena Morales-Marente
Relational developmental systems theory integrates a positive youth development (PYD) perspective on the transition to adulthood. Meanwhile, the developmental assets (DAs) model describes the personal and contextual resources that nurture PYD. This study examined the fulfillment of DAs and experience of social contribution in a sample of 23 Spanish undergraduates from seven universities (age range 18–25, M age = 20.57, SD = 2.06). Data were collected from seven focus groups, each comprising undergraduate students from different academic years, universities, and degree programs. All interviews were conducted in Spanish for 50–65 min and comprised eight questions divided into three sections (internal assets, external assets, and social contribution and barriers). The results indicated that among internal assets, positive values, social competencies, and positive identity were important for adolescents. Additionally, the external asset of social support was a highly relevant resource. Regarding social contribution, the participants showed empathy towards the needs of the community and reported that helping others was rewarding. Clearly, the youth’s perspectives on their development should be considered while creating prevention and promotion programs that foster internal and external assets.

11 September 2023 in European Journal of Neurology
Verified
Journal Article
Open access
LNLaia Nou‐Fontanet
Laia Nou‐Fontanet
CMCarmen Martín‐Gómez
Carmen Martín‐Gómez
RIRebeca Isabel‐Gómez
Rebeca Isabel‐Gómez
ABAnne-Catherine Bachoud-Lévi
Anne-Catherine Bachoud-Lévi
GZGiovanna Zorzi
Giovanna Zorzi
JOJuan Darío Ortigoza‐Escobar
Juan Darío Ortigoza‐Escobar
Background: The NKX2‐1‐related disorders (NKX2‐1‐RD) is a rare disorder characterized by choreiform movements along with respiratory and endocrine abnormalities. The European Reference Network of Rare Neurological Disorders funded by the European Commission conducted a systematic review to assess drug treatment of chorea in NKX2‐1‐RD, aiming to provide clinical recommendations for its management.Methods: A systematic pairwise review using various databases, including MEDLINE, Embase, Cochrane, CINAHL, and PsycInfo, was conducted. The review included patients diagnosed with chorea and NKX2‐1‐RD genetic diagnosis, drug therapy as intervention, no comparator, and outcomes of chorea improvement and adverse events. The methodological quality of the studies was assessed, and the study protocol was registered in PROSPERO.Results: Of the 1417 studies examined, 28 studies met the selection criteria, consisting of 68 patients. The studies reported 22 different treatments for chorea, including carbidopa/levodopa, tetrabenazine, clonazepam, methylphenidate, carbamazepine, topiramate, trihexyphenidyl, haloperidol, propranolol, risperidone, and valproate. No clinical improvements were observed with carbidopa/levodopa, tetrabenazine, or clonazepam, and various adverse effects were reported. However, most patients treated with methylphenidate experienced improvements in chorea and reported only a few negative effects. The quality of evidence was determined to be low.Conclusions: The management of chorea in individuals with NKX2‐1‐RD presents significant heterogeneity and lack of clarity. While the available evidence suggests that methylphenidate may be effective in improving chorea symptoms, the findings should be interpreted with caution due to the limitations of the studies reviewed. Nonetheless, more rigorous and comprehensive studies are necessary to provide sufficient evidence for clinical recommendations.

19 February 2025 in Patient Education and Counseling
Verified
Journal Article
Open access
AGAnabel Granja-Dominguez
Anabel Granja-Dominguez
CMCarmen Martin-Gomez
Carmen Martin-Gomez
JOJuan Darío Ortigoza-Escobar
Juan Darío Ortigoza-Escobar
RRRocío Rodriguez-Lopez
Rocío Rodriguez-Lopez
LGLourdes Gonzalez-Bermudez
Lourdes Gonzalez-Bermudez
JBJuan Antonio Blasco-Amaro
Juan Antonio Blasco-Amaro
Develop a proposal to involve people living with rare and complex conditions in the development of clinical practice guidelines (CPGs) based on a systematic review of qualitative literature. A systematic review was conducted using medical subject heading-term and text-word search strategies to identify qualitative literature on patient living with rare diseases (PLWRD) involvement during CPG development and in research studies. Databases were searched for literature in English or Spanish, published until April 2024. 64 publications were included in this review, underscoring the critical importance of PLWRD involvement in the CPGs development. The studies reported different strategies to facilitate the involvement of patients and collect relevant information from the patient community. The Guideline Development Group and the Core Writing Group should include representatives of the patient community, closely communicating with a patient advisory group to facilitate a broader patient perspective. Patient representatives should be engaged throughout all stages of CPG development, from defining the scope to implementation. This proposal offers a framework for actively involve PLWRD throughout the CPGs development process, aiming to produce more inclusive and practical recommendations that better reflect real-world patient needs.